Last reviewed · How we verify
NCT06120218: TOESIS
Tandem Occlusion After Emergent Stenting in Acute Ischemic Stroke
NA trial testing Emergent Stenting in Acute Stroke in 110 participants. Currently enrolling.
30 September 2025
Quick facts
| Lead sponsor | Can Tho Stroke International Services Hospital |
|---|---|
| Phase | NA |
| Status | Recruiting now |
| Study type | INTERVENTIONAL |
| Allocation | non randomized |
| Design | single group |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 110 |
| Start date | 1 December 2020 |
| Primary completion | 30 September 2025 |
| Estimated completion | 30 November 2025 |
| Sites | 1 location across Vietnam |
Drugs / interventions tested
- Emergent Stenting
Conditions studied
- Acute Stroke — all drugs for Acute Stroke →
- Ischemic Stroke, Acute — all drugs for Ischemic Stroke, Acute →
Sponsor
Can Tho Stroke International Services Hospital
Who can join
Adults 19 to 100, any sex, with Acute Stroke or Ischemic Stroke, Acute. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
In acute ischemic stroke due to tandem occlusion, the emergent stenting has recently become an endovascular treatment option combining with mechanical thrombectomy to achieve recanalization. However, the data on the beneficial endovascular management of tandem occlusion in two circulations is still limited. The purpose of our study was to compare the improvement of clinical outcome between two circulations after emergent stenting at 3 months.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT06120218
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Emergent Stenting
Trials testing the same drug.
- NCT06129721 — Emergent Stenting In Acute Vertebrobasilar Occlusions · NA · completed
Other recruiting trials for Acute Stroke
Currently open trials in the same condition.
- NCT07491952 — Continuous Dual Aspiration Technique With Zoom System for Stroke · recruiting
- NCT07295366 — Early Administration of PCSK9 Inhibitors After Thrombectomy for Atherosclerotic Acute Ischemic Stroke: A Randomized Cont · Phase 4 · recruiting
- NCT07355881 — mSOAR and Early Mortality in Acute Stroke · recruiting
- NCT07301372 — Evaluation Study of Early Administration of Evolocumab After Thrombolysis in Patients With Atherosclerotic Acute Ischemi · Phase 4 · recruiting
- NCT07167550 — The Study of Efficacy and Safety of Dimephosphon® in Acute Ischemic Stroke · Phase 3 · recruiting
Other Can Tho Stroke International Services Hospital trials
Trials by the same sponsor.
- NCT05644938 — Optimizing Door-to-reperfusion Times of One-stop Management in Acute Ischemic Stroke · NA · unknown
- NCT05947994 — Elucidate Outcomes of Elective High-grade/Total Occlusion Intracranial Arteries Using Low-profile Self-expanding Stent · NA · completed
- NCT06397638 — Rescue Carotid Stenting in Tandem Occlusions: 4-year Experience From a Comprehensive Stroke Centre · NA · completed
- NCT06129721 — Emergent Stenting In Acute Vertebrobasilar Occlusions · NA · completed
- NCT05666388 — Rescue Stenting in the Severe Atherosclerotic Stenosis After the Failure of Intravenous Thrombolysis · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06120218 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Can Tho Stroke International Services Hospital
- Last refreshed: 13 June 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06120218.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing